HIV Clinical Pathway: A New Approach to Combine Guidelines and Sustainability of Anti-Retroviral Treatment in Italy
نویسندگان
چکیده
The present article describes the case study of a "real world" HIV practice within the debate concerning the strategic role of Clinical Governance (CG) tools in the management of a National Healthcare System's sustainability. The study aimed at assessing the impact of a Clinical Pathway (CP) implementation, required by the Regional Healthcare Service, in terms of effectiveness (virological and immunological conditions) and efficiency (economic resources absorption), from the budget holder perspective. Data derived from a multi-centre cohort of patients treated in 6 Hospitals that provided care to approximately 42% of the total HIV+ patients, in Lombardy Region, Italy. Two phases were compared: Pre-CP (2009-2010) vs. Post-CP implementation (2011-2012). All HIV infected adults, observed in the participating hospitals during the study periods, were enrolled and stratified into the 3 categories defined by the Regional CP: first-line, switch for toxicity/other, and switch for failure. The study population was composed of 1,284 patients (Pre-CP phase) and 1,135 patients (Post-CP phase). The results showed that the same level of virological and immunological effectiveness was guaranteed to HIV+ patients: 81.2% of Pre-CP phase population and 83.2% of Post-CP phase population had undetectable HIV-RNA (defined as <50 copies/mL) at 12-month follow up. CD4+ cell counts increased by 28 ± 4 cells/mm3 in Pre-CP Phase and 39 ± 5 cells/mm3 in Post-CP Phase. From an economic point of view, the CP implementation led to a substantial advantage: the mean total costs related to the management of the HIV disease (ART, hospital admission and laboratory tests) decreased (-8.60%) in the Post-CP phase (p-value < 0.0001). Results confirmed that the CP provided appropriateness and quality of care, with a cost reduction for the budget holder.
منابع مشابه
بهرهمندی بیماران آلوده به HIV/AIDS از خدمات تعیینشده دستورالعمل کشوری بیماری ایدز
Background: Behavioral Consultation Centers are the main organizations responsible for providing HIV/AIDS patients with services according to the Iranian Ministry of Health guidelines. In this study we assessed provision of these supposed services to Iranian HIV/AIDS patients referring to Behavioral Consultation Centers. Methods: One hundred seventy one clinical files were selected by systemat...
متن کاملStudy of Anti-Retroviral Effects of Salix Aegyptiaca L Herbal Extract on HIV-1 in-vitro
Human immunodeficiency virus (HIV) infection is the major problem in the world. Nowadays, new anti-retroviral drugs are extracted from medicinal plants, make an important role to supersede synthetic drugs with different side effects. In this study, we studied the Salix aegyptiaca L extract, Iranian herb, as an anti-HIV drug with anti-retroviral effects. We used a single cycle replicable (SCR) H...
متن کاملEffects of Resistance Training and Lifestyle Modification on TCD4+cell Count and Body Composition of HIV+ Patients
Background and purpose: Anti-retroviral therapy has raised life expectancy of HIV+ patients, but, it is associated with some adverse effects. Physical exercise as a non-pharmacological approach could be helpful in reducing some adverse effects. The aim of this study was to investigate the effectiveness of resistance training (RT) and lifestyle modification program (LMP) on TCD+ cell count and b...
متن کاملItalian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update December 2014.
*All members of the Italian HIV Guidelines Working Group are listed in the acknowledgment session. 1 National Institute for Infectious Diseases L. Spallanzani, IRCCS, Rome, Italy; 2Nadir Onlus, Rome, Italy; 3University of Tor Vergata, Rome, Italy; 4San Paolo Hospital, University of Milan, Milan, Italy; 5University of Milan, Milan, Italy; 6 S.M. Annunziata Hospital, Florence, Italy; 7University ...
متن کاملItalian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update 2016.
The Italian Society of Infectious and Tropical Diseases (SIMIT) of the Technical Health Committee, Ministry of Health (Sections L and M) of Italy have supported recommendations for the Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. This publication summarizes the latest updates to the 2016 version of the Italian Guidelin...
متن کامل